Sonnenschein Nath & Rosenthal LLP



Venture Capital / Emerging Growth Company Group

Print this page   Email this page to a colleague

Sonnenschein's Venture Technology Group is among the Top 10 firms nationally in venture capital deals as reported in Dow Jones Private Equity Analyst. Our success is driven by a multi-disciplinary team comprising more than 200 attorneys and other professionals specializing in:

  • Venture Capital
  • Incubation Services
  • IP & Patent Litigation
  • Licensing & IT Transactions
  • Corporate Governance
  • Recovery Act & Legislative Strategies
  • M&A and Strategic Advisory
  • Fund Services
  • Capital Markets / IPOs
  • Outsourcing / Asia

Sonnenschein's Venture Technology Group leverages its deep expertise in IT, life sciences and medical devices, digital media, clean technology, telecommunications, health care information technology and data privacy, along with a robust network of venture capital and investment banking firms from Silicon Valley to Boston and New York, to remove hurdles to your success.

For additional information, contact Victor H. Boyajian, Global Chair, Sonnenschein Venture Technology Group at vboyajian@sonnenschein.com or any of the partners on our leadership team.

TwitterFollow Sonnenschein's Venture Technology Group on Twitter to stay abreast of our group's insights, positions and commentary on important issues and trends affecting the venture capital ecosystem, as well as information about upcoming events, activities and programs.



Spotlight on Venture Capital Group
Craig Menden Moderates Mobile Content Panel at AlwaysOn Summit at Stanford
Craig Menden
Craig Menden, Partner in Sonnenschein's Venture Technology Group moderated the panel "Mobile Content Creation, Distribution and Consumption" on July 28, 2010.  Speakers included Bling Nation, BOKU, MobiTV, Verizon Ventures and GrandBanks Capital.
View video from Craig Menden's presentation.
Sonnenschein Hosts Life Sciences Event on $1B Tax Credit/Grant Opportunity Via Health Care Reform
Sonnenschein's Venture Technology Group will be hosting a Life Sciences/Health Care Reform event on the evening of May 25 in our New York midtown officeL. Robert Guenthner and Ira L. Kotel will present to emerging growth life sciences companies and VC's on the $1B Therapeutic Tax Credit/Grant opportunity through Health Care Reform.
Sonnenschein Ranks in Top 10 Nationally for Venture and Private Equity Deals
For the third straight year, Sonnenschein Nath & Rosenthal LLP is ranked in the top 10 among law firms nationwide for the number of venture capital deals completed, according to Dow Jones Private Equity Analyst.  The firm also earned a top 10 ranking for the number of venture capital and private equity deals completed in 2009 – another indicator of Sonnenschein's strength in the marketplace.  Click here to read the news release.
Tech Giants Google, Cisco and SAP plus Credit Suisse Join Sonnenschein For Tech M&A Webinar
Victor Boyajian
Victor Boyajian, Global Chair of Sonnenschein's Venture Technology Group, discusses cutting edge issues shaping the tech M&A landscape, including factors driving current M&A activity, deal structuring trends, earnouts and indemnities, post acquisition employee retention strategies and the next wave of M&A activity.  Speakers include M&A executives from Google, Cisco, SAP and Credit Suisse and Craig Menden, a partner in our Silicon Valley office.

Click here to view the presentation
Click here to listen to the audio
Chip Korn Examines the Market for Venture Investing in Cleantech
Chip Korn
Sonnenschein partner Chip Korn analyzes the factors driving venture investments in cleantech, to include a look at the hottest areas attracting capital, the impact of government stimulus funds, the funding outlook for emerging growth companies and the latest trends in deal terms, as well as what we can expect in the year to come.  Click here to view the interview from LegalMindsTV.